 Home > Medical News > Medicines Company News > Ruike Biologics Announces the Latest Progress of Phase III Clinical Development of Recombinant Nine-valent HPV Vaccine

Ruike Biologics Announces the Latest Progress of Phase III Clinical Development of Recombinant Nine-valent HPV Vaccine

 Last Update: 2022-08-20
 Source: Internet
 Author: User

Tags

paint stripping company

gorman rupp company

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Jiangsu Recco Biotechnology Co.

The phase III clinical trial of REC603 in China consists of three parts: the main efficacy trial, the immune bridging trial in small age groups, and the immunogenicity comparison trial with Gardasil? For 16,050 cases:

Main efficacy trial: In healthy women aged 18-45 years, evaluating the protective efficacy of high-grade cervical, vulvar, and vaginal high-grade intraepithelial neoplasia and above lesions associated with high-risk HPV infection contained in the experimental vaccine is the primary efficacy endpoint.

Small age group immune bridging trial: evaluating the non-inferiority of serum neutralizing antibodies in healthy women aged 9-17 years compared with healthy women aged 18-45 at 1 month after full-scale vaccination with the experimental vaccine

Immunogenicity Comparison Trial with Gardasil® 9: To evaluate the non-inferiority of serum neutralizing antibodies compared with Gardasil® 9 at 1 month after full vaccination with the test vaccine in healthy women aged 16-26 years

The nine-valent HPV vaccine can prevent approximately 90% of cervical cancers and 90% of anal and genital warts, and is widely regarded as the most effective vaccine against HPV

Jiangsu Recco Biotechnology Co.

The nine-valent HPV vaccine can prevent approximately 90% of cervical cancers and 90% of anal and genital warts, and is widely regarded as the most effective vaccine against HPV

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.